Indoor Biotechnologies (IB) is an immunodiagnostics and biotechnology company specializing in manufacturing innovative products for investigating environmental and immunologic aspects of asthma and allergic diseases. The company's technology includes a comprehensive set of monoclonal antibodies for the detection of house dust mite, cat, dog, cockroach and fungal allergens. IB has a worldwide exclusive licence to market these antibodies from the University of Virginia Patent Foundation. IB has developed a range of innovative allergen detection systems, including laboratory based ELISA and a consumer based rapid test kit, which detects mite allergen in the home within 10 minutes. These systems provide a complete range of tests for assessing environmental exposure to indoor allergens; for testing the efficacy of allergen avoidance procedures, products and devices, for allergen standardization and product development. IB is the world leader in environmental allergen detection systems. IB technology is used worldwide and has been reported in over 250 scientific publications on indoor allergens. IB operates an INDOOR® Allergen Analysis Service, Contract Research Services and Professional Training Courses. IB introduced natural and recombinant allergens as a new product line for research use and for developing new strategies for allergy diagnosis and treatment. This range of products currently includes the most important dust mite, cat and cockroach allergens. IB has an extensive product pipeline and ambitious plans for developing consumer based allergy diagnostic devices and environmental products. IB was founded by Dr. Martin D. Chapman, formerly Professor of Medicine and Microbiology at the University of Virginia and a member of the UVA Asthma and Allergic Diseases Center. Dr. Chapman is a Fellow of the American Academy of Allergy, Asthma and Immunology and has served as a consultant to the U.S. National Institutes of Health, the Environmental Protection Agency, and several biotechnology and environmental products companies. IB is organized as two affiliated companies, INDOOR Biotechnologies Inc. (IBI), located in Charlottesville, Virginia, USA, and INDOOR Biotechnologies Limited (IBL) based in Warminster, UK. IBI carries out research, development and sales in the Americas and IBL handles sales, distribution and business development in Europe, the Far East, Australia and New Zealand. For further information, please contact: Dr. Martin D. Chapman INDOOR Biotechnologies Inc 1216 Harris Street Charlottesville, VA 22903
Founded in 2000, Chemogen is a privately held company focused on developing novel proprietary tests for the diagnosis of infectious diseases, initially tuberculosis. Chemogen's scientific team, led by Dr. Vladimir Koulchin, has developed a revolutionary urine-based TB diagnostic test, capable of accelerating TB detection and playing an important role in eradicating tuberculosis while opening significant market opportunities worldwide. Chemogen's technology is adaptable to multiple existing diagnostic formats. Chemogen's test demonstrates better performance than the current standard of sputum microscopy in those co-infected with TB and HIV. The test is highly effective in screening for active TB in HIV-positive individuals, and is significantly easier to use than competing technologies.
CTK develops and manufactures innovative immunodiagnostic test kits for the IVD community worldwide. We have a unique IVD business model in that we produce our own recombinant antigens and antibodies for later use in the production of our test kits. Our skill in obtaining and purifying these raw materials gives us an edge over our competitors as we can guarantee that our clients receive the highest quality products at exceptional pricing. Customer service is the most important factor to our business. We strive to obtain and retain our loyal customers by exceeding their expectations with quality products, competitive pricing, and unparalleled service. From raw material production to test kit manufacturing and registration, CTK is known for excellence in quality.
ContraVac, located in Charlottesville, VA, develops products for male reproductive healthcare in cooperation with the Center for Research in Contraceptive and Reproductive Health at the University of Virginia which is directed by ContraVac's founder, Dr. John Herr, Ph.D. ContraVac is dedicated to developing and commercializing research discoveries into innovative diagnostics for male reproductive health care. Through an in-license agreement with the University of Virginia Patent Foundation, ContraVac has obtained exclusive world-wide rights to certain University of Virginia patents related to sperm specific antigens, their complementary antibody reagents and their methods of use.
MEDICORP manufactures and markets state-of-the-art immunoassay products, Monoclonal Antibodies for Neuroscience and a broad line of Polyclonal Antibodies to Peptide and Steroid hormones in Canada and through distributors in Europe and Asia. MEDICORP's Free PSA [ fPSA] assay has revolutionized the differential diagnosis of prostate cancer.
Microbix Biosystems Inc. is a Canada-based company. The Company is engaged in the development, manufacturing and distribution of cell-based products and technology and, provision of facility, technical and production personnel for contract research and development. Sequent Biotechnologies Inc. is the Company’s wholly owned subsidiary. In September 2008, the Company announced that it has divested its urokinase business to Microbix Biosystems Inc. Through this transaction, Microbix has acquired the remaining urokinase inventory and related assets and has assumed full responsibility for ongoing commercial and regulatory activities associated with the product. Urokinase is an United States Food and Drug association (FDA)-approved thrombolytic, or clot-dissolving agent, indicated for the treatment of acute massive pulmonary embolism.
Privacy Policy | Terms and Conditions | Do Not Sell My Personal Information | Websites Directory
Copyright © 2022 kwtbox.com. All Rights Reserved. US Business Directory